Navigation Links
Glycosal HbA1c Tester

ProductsGlycosal HbA1c Tester
Company Provalis
Item Glycosal HbA1c Tester
Features 
  • CLIA waiver.
  • Prescription home use status in the US.
  • Standardised to the Diabetes Control and Complications Trial (DCCT).
  • Certified by the European Reference Laboratory, to ensure traceability of results to the DCCT.
  • Compared to the major laboratory methods of HbA1c testing and achieved correlation in excess of r = 0.97 with all of them.
  • Normal and abnormal HbA1c controls are available to allow users of the test to carry out their own Quality Control.
  • The HaemaQuant instrument incorporates software to eliminate user error.
  • Manufactured to the highest ISO9001 requirements.
  • Participates in external quality assessment schemes to ensure on-going performance.
  • Certified by the National Glycohaemoglobin Standardisation Programme (NGSP) in the USA.
Description Long term complications associated with diabetes continue to have a tremendous impact on the health and quality of life of patients, in addition to the significant economic costs. These complications are known to be associated with elevated levels of blood glucose. The discovery that the level of haemoglobin A1c (HbA1c) in a diabetic patient's blood, reflects the average blood glucose concentration over the previous 90-120 day period, was a significant aid to treatment of the disease.
Info Provalis
Customer Service: +44 (0) 1244 288 888
Web site: http://www.provalis.com/HTMLFiles/start.html

Related medicine products :

1. A1c-Cellular HbA1c Control
2. Haemoglobin (HbA1c)
3. Haemoglobin (HbA1c/Hb) Liquid
4. HbA1c/Hb Calibrator Series
5. Afinion HbA1c test
6. Brightness Acuity Tester (BAT)
7. Optec 3500 Vision Tester
8. Optec Vision Tester
9. Donna® Saliva Ovulation Tester
10. Precision Xtra Advanced Diabetes Tester
11. Optec 6500P Vision Tester
Breaking Medicine Technology:Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Reportlinker Adds Training Manikins - Global Trends 2Reportlinker Adds Training Manikins - Global Trends 3Reportlinker Adds Training Manikins - Global Trends 4Reportlinker Adds Training Manikins - Global Trends 5Deloitte Report 3A Pharmaceutical Companies Patent Cliff Could Bolster Mergers and Acquisitions 5738 1Deloitte Report 3A Pharmaceutical Companies Patent Cliff Could Bolster Mergers and Acquisitions 5738 2Olympus introduces the VisiGlide a single use guidewire 10540 1Olympus introduces the VisiGlide a single use guidewire 10540 2Nepal expands critical tiger habitat 10535 1Nepal expands critical tiger habitat 10535 2